Home
/ ZAI Lab
/ Competitors

ZAI Lab Competitors and Similar CompaniesClear all

ZAI Lab's competitors and similar companies include BGI Genomics and Shanghai Junshi Biosciences.

	ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases.	BGI Genomics BGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services.	Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
Founding Date	Founding Date 2014	Founding Date 1999	Founding Date 2012
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development medical devices oncology pharma therapy	Tags Healthcare biotech genetics medical diagnostics oncology	Tags Healthcare biotech drug development oncology pharma
Locations	Locations CN HQ Suzhou, CN Hong Kong, HK Taipei, TW Cambridge, US Menlo Park, US	Locations Shenzhen, CN HQ Brisbane, AU Copenhagen, DK Addis Ababa, ET Hong Kong, HK Budapest, HU Kobe, JP see more	Locations Shanghai, CN HQ
Employees	Employees 1,869	Employees 3,702	Employees 2,578
Valuation ($)	Valuation ($) 3.2 b	Valuation ($) 2.7 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $460.2m (FY, 2025)	Revenue (est.) ¥3.7b (FY, 2025)	Revenue (est.) ¥2.4b (FY, 2025)
Cost of goods	Cost of goods $190.5m (FY, 2025)	Cost of goods ¥2.3b (FY, 2025)	Cost of goods ¥466.5m (FY, 2025)
Gross profit	Gross profit $269.6m (FY, 2025)	Gross profit ¥1.4b (FY, 2025)	Gross profit ¥2b (FY, 2025)
Net income	Net income ($175.5m) (FY, 2025)	Net income (¥637.8m) (FY, 2025)	Net income (¥1b) (FY, 2025)